Genetic heterogeneity of Alzheimer’s disease in subjects with and without hypertension

[1]  Anatoliy I. Yashin,et al.  Genome-wide analysis of genetic predisposition to Alzheimer’s disease and related sex disparities , 2018, Alzheimer's Research & Therapy.

[2]  Sina A. Gharib,et al.  Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood , 2018, Nature Communications.

[3]  W. Hsu,et al.  Smad4 SUMOylation is essential for memory formation through upregulation of the skeletal myopathy gene TPM2 , 2017, BMC Biology.

[4]  Thawfeek M. Varusai,et al.  The Reactome Pathway Knowledgebase , 2017, Nucleic Acids Res..

[5]  B. Zlokovic,et al.  Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.

[6]  David Haussler,et al.  The UCSC Genome Browser database: 2018 update , 2017, Nucleic Acids Res..

[7]  R. Swerdlow.  Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[8]  G. Tosto,et al.  Genetics of Alzheimer’s Disease: the Importance of Polygenic and Epistatic Components , 2017, Current Neurology and Neuroscience Reports.

[9]  Grant R. Gordon,et al.  Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline , 2017, Experimental Gerontology.

[10]  T. Kiss,et al.  Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease , 2017, GeroScience.

[11]  A. Heerschap,et al.  Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  F. Deák,et al.  Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment , 2017, GeroScience.

[13]  T. Kiss,et al.  Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer’s disease using functional laser speckle contrast imaging , 2017, GeroScience.

[14]  S. Tarantini,et al.  Cerebral microhemorrhages: mechanisms, consequences, and prevention. , 2017, American journal of physiology. Heart and circulatory physiology.

[15]  Jing Zhao,et al.  The Genetic Architecture of Gene Expression in Peripheral Blood. , 2017, American journal of human genetics.

[16]  Helen E. Parkinson,et al.  The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) , 2016, Nucleic Acids Res..

[17]  Walter H. Backes,et al.  Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging , 2016, Neurobiology of Aging.

[18]  Y. Hsueh,et al.  AIM 2 inflammasomes regulate neuronal morphology and influence anxiety and memory in mice , 2016, Scientific Reports.

[19]  Cory B. Giles,et al.  Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging , 2016, AGE.

[20]  Iryna Leshchyns’ka,et al.  Synaptic Cell Adhesion Molecules in Alzheimer's Disease , 2016, Neural plasticity.

[21]  R. Cacabelos.  The Complexity of Alzheimers Disease Pharmacogenomics and Metabolomics in Drug Development , 2016 .

[22]  Alzheimer’s Association,et al.  2016 Alzheimer's disease facts and figures , 2016, Alzheimer's & Dementia.

[23]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[24]  R. Keep,et al.  Junctional proteins of the blood-brain barrier: New insights into function and dysfunction , 2016, Tissue barriers.

[25]  C. Iadecola,et al.  Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  Wei Zhang,et al.  Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  L. Stein,et al.  The Reactome pathway Knowledgebase , 2015, Nucleic Acids Res..

[28]  Mitchell J. Machiela,et al.  LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..

[29]  B. Winblad,et al.  Proton myo‐inositol cotransporter is a novel γ‐secretase associated protein that regulates Aβ production without affecting Notch cleavage , 2015, The FEBS journal.

[30]  A. Richardson,et al.  How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story , 2015, Experimental Gerontology.

[31]  Tobias M. Rasse,et al.  Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity. , 2015, Human molecular genetics.

[32]  Fuhai Song,et al.  Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer’s Disease , 2015, Molecular Neurobiology.

[33]  Timothy A Thornton,et al.  Robust Inference of Population Structure for Ancestry Prediction and Correction of Stratification in the Presence of Relatedness , 2015, Genetic epidemiology.

[34]  M. Portero-Otín,et al.  Deregulation of purine metabolism in Alzheimer's disease , 2015, Neurobiology of Aging.

[35]  Arthur W. Toga,et al.  Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.

[36]  Marylyn D. Ritchie,et al.  Imputation and quality control steps for combining multiple genome-wide datasets , 2014, Front. Genet..

[37]  Franco Cauda,et al.  Node Detection Using High-Dimensional Fuzzy Parcellation Applied to the Insular Cortex , 2014, bioRxiv.

[38]  J. Yeh,et al.  Cohen’s h for detection of disease association with rare genetic variants , 2014, BMC Genomics.

[39]  C. Brayne,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[40]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[41]  Richard Leslie,et al.  GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database , 2014, Bioinform..

[42]  Juan Zhang,et al.  Lipid metabolism in Alzheimer’s disease , 2014, Neuroscience Bulletin.

[43]  Olivier Salvado,et al.  Incidence of cerebral microbleeds in preclinical Alzheimer disease , 2014, Neurology.

[44]  Amanda Sonnega,et al.  Cohort Profile: the Health and Retirement Study (HRS). , 2014, International journal of epidemiology.

[45]  B. Zlokovic,et al.  Pericyte loss influences Alzheimer-like neurodegeneration in mice , 2013, Nature Communications.

[46]  A. Gambardella,et al.  Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer’s disease , 2013, Journal of Neural Transmission.

[47]  Koichiro Tamura,et al.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.

[48]  D. Sosnowska,et al.  Age-Related Autoregulatory Dysfunction and Cerebromicrovascular Injury in Mice with Angiotensin II-induced Hypertension , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  C. Iadecola,et al.  Hypertension: A Harbinger of Stroke and Dementia , 2013, Hypertension.

[50]  V. Burt,et al.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. , 2013, NCHS data brief.

[51]  E. Hol,et al.  Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model , 2013, Neurobiology of Aging.

[52]  R. Malinow,et al.  Metabotropic NMDA receptor function is required for β-amyloid–induced synaptic depression , 2013, Proceedings of the National Academy of Sciences.

[53]  G. Ricevuti,et al.  Alzheimer disease and platelets: how’s that relevant , 2012, Immunity & Ageing.

[54]  B. Zlokovic,et al.  Hypertension Induces Brain &bgr;-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature , 2012, Hypertension.

[55]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[56]  K. Yaffe,et al.  The projected effect of risk factor reduction on Alzheimer's disease prevalence , 2011, The Lancet Neurology.

[57]  Deborah Blacker,et al.  The Association Between Blood Pressure and Incident Alzheimer Disease: A Systematic Review and Meta-analysis , 2011, Epidemiology.

[58]  P. Aloy,et al.  Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. , 2011, Genome research.

[59]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[60]  M. Zhang,et al.  Angiotensin II induced cerebral microvascular inflammation and increased blood–brain barrier permeability via oxidative stress , 2010, Neuroscience.

[61]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[62]  Y. Kokubo,et al.  A genome-wide association study of hypertension-related phenotypes in a Japanese population. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[63]  Min-Ju Kim,et al.  Glutamate carboxypeptidase II: an amyloid peptide‐degrading enzyme with physiological function in the brain , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  C. Bell,et al.  National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer Disease* and Cognitive Decline , 2010, Annals of Internal Medicine.

[65]  Reedik Mägi,et al.  GWAMA: software for genome-wide association meta-analysis , 2010, BMC Bioinformatics.

[66]  C. Bell,et al.  NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. , 2010, NIH consensus and state-of-the-science statements.

[67]  P. Martínez-Martín,et al.  Role of Hypertension in Aggravating Aβ Neuropathology of AD Type and Tau-Mediated Motor Impairment , 2009, Cardiovascular psychiatry and neurology.

[68]  C. Iadecola,et al.  Threats to the Mind: Aging, Amyloid, and Hypertension , 2009, Stroke.

[69]  R. Mayeux,et al.  Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. , 2008, Archives of neurology.

[70]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[71]  J. O’Connell,et al.  Accounting for Relatedness in Family Based Genetic Association Studies , 2007, Human Heredity.

[72]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[73]  M. Stampfer,et al.  Cardiovascular disease and Alzheimer's disease: common links , 2006, Journal of internal medicine.

[74]  George D. Mellick,et al.  Parkinson's Disease in Relation to Pesticide Exposure and Nuclear Encoded Mitochondrial Complex I Gene Variants , 2006, Journal of biomedicine & biotechnology.

[75]  R. Homayouni,et al.  The Creatine Kinase/Creatine Connection to Alzheimer's Disease: CK Inactivation, APP-CK Complexes, and Focal Creatine Deposits , 2006, Journal of biomedicine & biotechnology.

[76]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[77]  J. Goudet.  HIERFSTAT , a package for R to compute and test hierarchical F -statistics , 2005 .

[78]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[79]  Rhoda Au,et al.  Cerebral Microbleeds: Prevalence and Associations With Cardiovascular Risk Factors in the Framingham Study , 2004, Stroke.

[80]  W. Markesbery,et al.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆ , 2000, Neurobiology of Aging.

[81]  Richard Williams,et al.  Comparing Logit and Probit Coefficients Across Groups , 1999 .

[82]  P. Allison,et al.  Comparing Logit and Probit Coefficients Across Groups , 1999 .

[83]  N. Cairns,et al.  Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease , 1998, Neuroscience Letters.

[84]  P. R. Hof,et al.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders , 1994, Acta Neuropathologica.

[85]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[86]  M. Nei.  Molecular Evolutionary Genetics , 1987 .

[87]  B. Weir,et al.  ESTIMATING F‐STATISTICS FOR THE ANALYSIS OF POPULATION STRUCTURE , 1984, Evolution; international journal of organic evolution.

[88]  D. Hartl,et al.  Principles of population genetics , 1981 .

[89]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.

[90]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.

[91]  R. Maeba,et al.  Extrinsic effectors regulating genes for plasmalogen biosynthetic enzymes in HepG2 cells , 2017 .

[92]  É. Thorin.  Hypertension and Alzheimer disease: another brick in the wall of awareness. , 2015, Hypertension.

[93]  J. Attems,et al.  Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats. , 2014, Journal of Alzheimer's disease : JAD.

[94]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[95]  鄭素梅,et al.  Nature Publishing Group , 2006 .

[96]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[97]  Kevin F Krenitsky,et al.  patient-oriented and epidemiological research Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer’s disease and dementia , 2007 .

[98]  Taylor J. Maxwell,et al.  A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. , 2006, American journal of human genetics.

[99]  N. Sakata,et al.  Pathologic evidence of microvascular rarefaction in the brain of renal hypertensive rats. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[100]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[101]  Andrew C. Leon,et al.  Sample sizes required to detect interactions between two binary fixed-effects in a mixed-effects linear regression model , 2009, Comput. Stat. Data Anal..